Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis.

PURPOSE To perform a meta-analysis of long-term results of balloon dilation and stent implantation in the treatment of femoropopliteal arterial disease. MATERIALS AND METHODS The English-language literature was searched for studies published between 1993 and 2000. Inclusion criteria for articles were presentation of long-term primary patency rates, standard errors (explicitly reported or derivable), and baseline characteristics of the study population. Two reviewers independently extracted data, and discrepancies were resolved by consensus. Primary patency rates were combined by using a technique that allows adjustment for differences across study populations. Analyses were adjusted for lesion type and clinical indication. RESULTS Nineteen studies met the inclusion criteria, representing 923 balloon dilations and 473 stent implantations. Combined 3-year patency rates after balloon dilation were 61% (standard error, 2.2%) for stenoses and claudication, 48% (standard error, 3.3%) for occlusions and claudication, 43% (standard error, 4.1%) for stenoses and critical ischemia, and 30% (standard error, 3.7%) for occlusions and critical ischemia. The 3-year patency rates after stent implantation were 63%-66% (standard error, 4.1%) and were independent of clinical indication and lesion type. Funnel plots demonstrated an asymmetric distribution of the data points associated with stent studies. CONCLUSION Balloon dilation and stent implantation for claudication and stenosis yield similar long-term patency rates. For more severe femoropopliteal disease, the results of stent implantation seem more favorable. Publication bias could not be ruled out.

[1]  H. Lau,et al.  Immediate stenting of iliofemoral occlusive lesions: a surgeon's early experiences. , 1999, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[2]  J B Wong,et al.  Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. , 1995, JAMA.

[3]  E P Strecker,et al.  Femoropopliteal artery stent placement: evaluation of long-term success. , 1997, Radiology.

[4]  R. Rutherford,et al.  Recommended standards for reports dealing with lower extremity ischemia: revised version. , 1997, Journal of vascular surgery.

[5]  R. McLafferty,et al.  Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries. , 2000, Journal of vascular surgery.

[6]  C. Begg,et al.  Publication bias : a problem in interpreting medical data , 1988 .

[7]  A. Tielbeek,et al.  Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. , 1996, Journal of vascular and interventional radiology : JVIR.

[8]  J. Becquemin,et al.  Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. , 1994, Journal of vascular surgery.

[9]  A V Uchôa,et al.  [Percutaneous transluminal angioplasty]. , 1982, AMB : revista da Associacao Medica Brasileira.

[10]  J. Murray,et al.  Long-segment (> or = 10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. , 1995, Radiology.

[11]  S. Katz,et al.  Percutaneous Transluminal Angioplasty of Infrainguinal Vessels , 1999, Annals of vascular surgery.

[12]  F. Casselman,et al.  Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease. A preliminary evaluation of fifty-five patients. , 1996, Journal of vascular surgery.

[13]  D. Taylor,et al.  Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia. , 1996, Journal of vascular surgery.

[14]  D. Harrington,et al.  Patency Results of Percutaneous and Surgical Revascularization for Femoropopliteal Arterial Disease , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[15]  D. Cossman,et al.  Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty. , 1994, Journal of vascular surgery.

[16]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[17]  K. Dear,et al.  Iterative generalized least squares for meta-analysis of survival data at multiple times. , 1994, Biometrics.

[18]  W. Hop,et al.  Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. , 1995, Journal of vascular surgery.

[19]  W. Mali,et al.  Recanalization of femoropopliteal occlusive lesions: a comparison of long-term clinical, color duplex US, and arteriographic follow-up. , 1995, Journal of vascular and interventional radiology : JVIR.

[20]  G. White,et al.  No additional benefit from laser in balloon angioplasty of the superficial femoral artery. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[21]  Michael R. Chernick,et al.  Analysis of Survival Times , 2003 .

[22]  R. Pélissier,et al.  Long-term results with the Palmaz stent in the superficial femoral artery. , 1995 .

[23]  A. Davies,et al.  Outcome of femoropopliteal angioplasty. , 1999, Annals of surgery.

[24]  D. Kessel,et al.  Endovascular stent-grafts for superficial femoral artery disease: results of 1-year follow-up. , 1999, Journal of vascular and interventional radiology : JVIR.

[25]  W. Jeans,et al.  Angioplasty gives good results in critical lower limb ischaemia. A 5-year follow-up in patients with known ankle pressure and diabetic status having femoropopliteal dilations. , 1994, The British journal of radiology.

[26]  U. Albrechtsson,et al.  Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. , 1999, International angiology : a journal of the International Union of Angiology.

[27]  M. Henry,et al.  Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up. , 1995, Radiology.

[28]  S. Sultan,et al.  Outcome of the first 100 femoropopliteal angioplasties performed in the operating theatre. , 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[29]  C. Schmitt,et al.  Reimplantation of an infected, abdominally implanted defibrillator in the subpectoral region. , 1996, The Journal of cardiovascular surgery.

[30]  R. Pélissier,et al.  Long-term Results with the Palmaz Stent in the Superficial Femoral Artery , 1995, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[31]  E. Diethrich,et al.  Multicenter trial of the wallstent in the iliac and femoral arteries. , 1995, Journal of vascular and interventional radiology : JVIR.

[32]  A. Tielbeek,et al.  Balloon Angioplasty Combined with Primary Stenting Versus Balloon Angioplasty Alone in Femoropopliteal Obstructions: A Comparative Randomized Study , 1997, CardioVascular and Interventional Radiology.

[33]  G. White,et al.  Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation. , 1995, Journal of vascular surgery.

[34]  R. Ashleigh,et al.  Regarding "Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome". , 1994, Journal of vascular surgery.

[35]  J. Lammer,et al.  PTA versus Stent in der femoropoplitealen Strombahn , 1999, Der Radiologe.